mRNA |
WP1130 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
mRNA |
S-Trityl-L-cysteine |
GDSC1000 |
pan-cancer |
AAC |
-0.19 |
0.0005 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0005 |
mRNA |
Bleomycin |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0007 |
mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.001 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
Nutlin-3a (-) |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
TGX221 |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
0.002 |